ClinicalTrials.gg
CompletedNCT02701751ATXUpdated Mar 21, 2022

Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study)

An interventional study of Exercise session in Healthy, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-21.

Sponsored by University of Michigan · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The primary purpose of this study is to examine the effects of chronic exercise training and an acute session of exercise on key risk factors associated with Metabolic Syndrome (e.g., glucose tolerance, blood lipid profile, and blood pressure) and alterations in subcutaneous adipose tissue structure and metabolic function in overweight adults.

Read the detailed description

Subjects will be asked to complete the Substrate Metabolism Laboratory General Screening Questionnaire and American Heart Association Health/Fitness Questionnaire to determine if they are eligible to complete the preliminary testing procedures. If eligible, subjects will be asked to visit the Substrate Metabolism Laboratory to participate in the preliminary testing procedures (listed below) before participating in the experimental trial.

PRELIMINARY TESTING PROCEDURES:

  • Blood pressure, height and weight measurements
  • Body Composition Assessment (\~20 min)
  • Exercise Fitness Test (\~10 min)
  • Resting Metabolic Rate (RMR) measurement (\~30 min)
  • 3 hour Oral Glucose Tolerance Test (OGTT)

EXPERIMENTAL TRIAL:

The evening before the experimental trial, subjects will eat a standardized dinner meal and snack. The meal and snack must be eaten at specific times as indicated by the research staff. After eating the snack, subjects will need to fast (no food or beverages - besides water) overnight.

Participants who exercise regularly will be instructed to exercise exactly 3 days before the experimental trial, and then abstain from their exercise training program until after the study is complete.

In the morning, subjects will return to the Substrate Metabolism Laboratory. The research team will collect a blood sample from the subject's hand or forearm and a small sample of fat tissue in the subject's abdomen with a needle. Next, subjects will exercise on a treadmill at a moderate intensity for about 1 hour. Immediately after exercising the research team will collect a second blood sample. Subjects will remain in the laboratory for 1 hour after exercising, and then the research team will collect another blood and fat tissue sample. Upon completion of the experimental trial, subjects will be provided a snack before leaving the laboratory.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

University of Michigan is the lead sponsor of 1,503 studies on the registry; 189 are open to participants now.

Of its 167 completed or terminated interventional studies of FDA-regulated products, 132 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: 18-40
  • Body Mass Index: 25-35 kg/m2
  • Regular exercisers: (≥4 days/wk of aerobic exercise; 30-60min/session at moderate and vigorous intensities)
  • Non-exercisers: no regularly planned exercise/physical activity
  • Women must have regularly occurring menses and must be premenopausal

Exclusion criteria

Exclusion Criteria:

  • Blood pressure > 140/90 mm Hg
  • Pregnant or lactating
  • Evidence/history of cardiovascular or metabolic disease
  • Medications known to affect lipid or glucose metabolism
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Other
    Exercise session

    Subjects will exercise at a moderate intensity for 60 minutes. There are no different arms in this study.

    Other: Exercise session

Interventions

  • OtherExercise session

    A blood sample and fat biopsy will be obtained before and after the 60 minute moderate exercise session. There is no drug or device intervention in this study.

06

What researchers measure

Primary outcomes

  1. PPARg mRNA expression

    The study team will quantify the abundance of key adipogenic markers in adipose tissue biopsy samples

    Time frame: change from baseline at 1 hour post exercise

  2. Cytokine abundance in adipose tissue

    The study team will measure cytokine proteins in adipose tissue

    Time frame: change from baseline at 1 hour post exercise

Secondary outcomes

  1. Total Cholesterol

    Plasma concentrations of total- cholesterol will be measured.

    Time frame: change from baseline at 1 hour post exercise

07

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02701751
Responsible party
Jeffrey F Horowitz (Professor, Movement Science; Director, Substrate Metabolism Laboratory, University of Michigan) — Principal investigator
First posted
Mar 8, 2016
Start date
Jan 2016
Primary completion
Oct 24, 2016
Completion
Oct 24, 2016
Last update
Mar 21, 2022

Study contacts

Jeffrey F Horowitz
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion